Do low DHEA-S levels reflect reduced adrenal androgen output and lower peripheral androgen availability?

Dehydroepiandrosterone sulfate (DHEA-S) is the most abundant circulating steroid precursor in humans, serving as a primary marker of adrenal function and a foundational reservoir for peripheral androgen synthesis.

Adrenal androgen output

• Low circulating DHEA-S levels directly reflect reduced adrenal secretory activity. Synthesized in the adrenal zona reticularis via ACTH-dependent pathways and sulfated by DHEA-sulfotransferase, DHEA-S has a long half-life and minimal diurnal variation, making it a highly stable marker for assessing adrenal androgen output.

Mechanistic pathways and peripheral availability

• DHEA-S is a critical precursor for localized, intracrine androgen synthesis in target tissues such as the skin, prostate, and adipose tissue.
• Peripheral cells utilize steroid sulfatase (STS) to desulfate DHEA-S into free DHEA, which is then converted by enzymes including 3β-HSD1, 17β-HSD, and 5α-reductase into active testosterone and dihydrotestosterone (DHT).
• This local tissue synthesis drives approximately 30% to 50% of total androgenic activity in men. Consequently, reduced DHEA-S directly limits the local precursor pool available for this intracrine conversion.

Circulating androgen contribution

• While DHEA-S is an essential reservoir for local tissues, its direct contribution to the systemic, active circulating androgen pool in healthy, eugonadal men is minimal, as testicular production of testosterone is dominant. However, the adrenal precursor pool becomes clinically significant for systemic status during testicular insufficiency or androgen deprivation.

Bottom line

• Low DHEA-S levels serve as a reliable indicator of reduced adrenal output; while DHEA-S contributes minimally to systemic circulating active androgens in healthy men, it is a crucial precursor that dictates 30% to 50% of total androgenic activity through localized, intracrine conversion in peripheral tissues.